Journals / Respiratory Case Reports / 2017 / Cilt: 6 - Sayı: 3

Hypereosinophilic Syndrome Diagnosed with Acute Coronary Syndrome

Akut Koroner Sendrom Kliniği ile Tanı Alan Hipereozinofilik Sendrom

Pages
157–160
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presently described is a patient with peripheral eosinophilia who had myocardial infarction at admission and was diagnosed with HES, a literature review, and discussion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypereosinophilic syndrome (HES) is a rare, multisystem, heterogeneous syndrome, characterized by a sustained overproduction of eosinophils, and in which eosinophilic infiltration can cause damage to multiple organs.
📊
Key Findings & Data:Cardiac involvement is frequent and carries with it a high rate of morbidity and mortality.
💡
Conclusion & Impact:Presently described is a patient with peripheral eosinophilia who had myocardial infarction at admission and was diagnosed with HES, a literature review, and discussion.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hypereosinophilic syndrome (HES) is a rare, multisystem, heterogeneous syndrome, characterized by a sustained overproduction of eosinophils, and in which eosinophilic infiltration can cause damage to multiple organs. Cardiac involvement is frequent and carries with it a high rate of morbidity and mortality. Presently described is a patient with peripheral eosinophilia who had myocardial infarction at admission and was diagnosed with HES, a literature review, and discussion.

Özet

Hipereozinofilik sendrom (HES) nadir görülen, çok sistemi tutabilen, heterojen bir sendrom olup, eozinofillerin aşırı üretilmesinin yol açtığı eozinofilik infiltrasyonun birden fazla organa zarar vermesine neden olabilir. Kardiyak tutulum sıklıkla görülür ve yüksek oranda morbidite ve mortalite taşır. Bu yazıda, tetkikleri esnasında miyokard enfarktüsü geçiren ve HES tanısı alan periferik eozinofilisi olan bir olgu literatür bilgileri eşliğinde sunulmaktadır.

🔖

Cite This Article

DEMİRCİ, N. Y., KAPLAN, M., TAÇOY, G., TÜRKTAŞ, H. Ş. (2017). Hypereosinophilic Syndrome Diagnosed with Acute Coronary Syndrome. Respiratory Case Reports, Cilt: 6 - Sayı: 3, 157–160. https://ajindex.com/articles/302455

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010; 126:45-9. [CrossRef] 2. Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart 2016; 102:100-6. [CrossRef] 3. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130:607-12. [CrossRef] 4. Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol 2010; 126:179-81. [CrossRef] 5. Lefebvre C, Bletry O, Degoulet P, Guillevin L, BentataPessayre M, Le Thi Huong Du, et al. Prognostic factors of hypereosinophilic syndrome. Study of 40 cases. Ann Med Interne (Paris) 1989; 140:253-7. 6. Roufosse F. Goldman M. Cogan E. Hypereosinophilic syndrome:lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med 2006; 27:158-70. [CrossRef] 7. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27: 457-75. [CrossRef] 8. Korczyk D, Taylor G, McAlistair H, May S, Coverdale A, Gibbs H, et al. Heart transplantation in a patient with endomyocardial fibrosis due to hypereosinophilic syndrome. Transplantation 2007; 83: 514-6. [CrossRef]